Prof. Herbert Kwok obtained his MBBS degree from the University of Hong Kong. He completed his specialty training in Respiratory Medicine and Advanced Internal Medicine at the Queen Mary Hospital. He joined the Department of Medicine, the University of Hong Kong, as a Clinical Assistant Professor subsequently.

Prof. Kwok’s research interests include airway diseases including asthma, bronchiectasis and chronic obstructive pulmonary diseases. Lung cancer is another area that Dr. Kwok is actively working on. He was awarded the Li Shu Fan Fellowship for Internal Medicine to support his study in phenotyping and therapeutics of airway diseases. He was also awarded competitive research grant to support his research in respiratory medicine, namely Health and Medical Research Fund, Pneumoconiosis Compensation Fund Board (PCFB) Research Fund, Hong Kong Lung Foundation Research Grant, Hong Kong College of Physicians Young Investigator Research Grant, Hong Kong Obesity Society Research Fund and The Hong Kong Institute of Allergy Research Grant.

Prof.. Kwok was awarded the APSR Travel Award to the JRS Annual Meeting 2024, Assembly Education Award [Respiratory Structure and Function Assembly] and [Respiratory Infections (non-tuberculous) Assembly] in the 26th Congress of the Asia Pacific Society of Respirology 2022, best oral presentation in the 8th Asia Pacific Region Conference of International Union Against Tuberculosis and Lung Disease (2022), Asian Pacific Society of Respirology Teaching Library Award (2019), best Abstract of the Assembly (Clinical Respiratory Medicine) in the 22nd Congress of the Asia Pacific Society of Respirology (2017) and Professor Wah-kit Lam Young Investigator Award 2017/2018 in recognition of his research work.

1. Vice-president, Hong Kong Public Doctor Association
2. Council member, Hong Kong Medical Association
3. Editor, Hong Kong Medical Journal
4. Editor, SciBase Critical Care and Emergency Medicine
5. Honorary Advisor for Paediatric Home Respiratory Support Society
6. Committee Member,  Scientic Committee And Newsletter and Website committee, Hong Kong Thoracic Society, CHEST Delegation Hong Kong & Macau, Hong Kong Lung Foundation
7. Young Fellow, Scientific Committee, Hong Kong College of Physicians

1. APSR Travel Award to the JRS Annual Meeting 2024
2. Assembly Education Award [Respiratory Structure and Function Assembly] 26th Congress of the Asia Pacific Society of Respirology 2022
3. Assembly Education Award [Respiratory Infections (non-tuberculous) Assembly] 26th Congress of the Asia Pacific Society of Respirology 2022
4. Best Oral presentation, 8th Asia Pacific Region Conference of International Union Against Tuberculosis and Lung Disease (APRC 2022)
5. Li Shu Fan Medical Scholarship for Internal Medicine 2020/21
6. Asian Pacific Society of Respirology Teaching Library Award 2019
7. Best Abstract of the Assembly (Clinical Respiratory Medicine) - 22nd Congress of the Asia Pacific Society of Respirology 2017
8. Professor Wah-kit Lam Young Investigator Award Merit 2017-2018
   
    

1. Cardiovascular outcomes following hospitalization for exacerbation of bronchiectasis - a territory-wide, BMJ Open Respir Res, 2024 [In press]  
2. Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severity, JTD, 2024 [In press]  
3. Kwok WC, Teo KC, Lau KK, Ho JC. High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk. BMC Pulm Med. 2024;24(1):80.  
4. Kwok WC, Tam TCC, Ho JCM, Lam DCL, Ip MS, Ho PL. Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation. Int J Chron Obstruct Pulmon Dis. 2024;19:77-86.  
5. Kwok WC, Ho JCM, Tam TCC, Ip MSM, Lam DCL. Increased exacerbations of bronchiectasis following recovery from mild COVID-19 in patients with non-cystic fibrosis bronchiectasis. Respirology. 2024.  
6. Kwok WC, Tam TCC, Ho JCM, Lam DCL, Ip MSM, Yap DYH. Hospitalized acute exacerbation in chronic obstructive pulmonary disease - impact on long-term renal outcomes. Respir Res. 2024;25(1):36.  
7. Kwok WC, Tam TCC, Lam DCL, Ip MSM, Ho JCM. Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis. Clin Respir J. 2023.  
8. Kwok WC, Ma TF, Ho JCM, Lam DCL, Sit KY, Ip MSM, et al. Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma. Respirology. 2023.  
9. Kwok WC, Chau CH, Tam TCC, Lam FM, Ho JCM. Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2023;18:1145-53.  
10. Kwok WC, Tam TCC, Sing CW, Chan EWY, Cheung CL. Validation of Diagnostic Coding for Asthma in an Electronic Health Record System in Hong Kong. J Asthma Allergy. 2023;16:315-21.  
11. Kwok WC, Ho JCM, Ma TF, Lam DCL, Chan JWM, Ip M, et al. Risk of hospitalised bronchiectasis exacerbation based on blood eosinophil counts. Int J Tuberc Lung Dis. 2023;27(1):61-5.  
12. Kwok WC, Tsoi MF, Leung SHI, Tsui CK, Tam TCC, Ho JCM, et al. Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting. Viruses [Internet] 2023;15(3):610.  
13. Kwok WC, Tam TCC, Lam DCL, Leung JKC, Chan KPF, Chan SKS, et al. Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respir Res. 2023;24(1):53.  
14. Kwok WC, Leung SHI, Tam TCC, Ho JCM, Lam DC, Ip MSM, et al. Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases. Int J Chron Obstruct Pulmon Dis. 2023;18:47-56.  
15. Kwok WC, Cheung KS, Ho JCM, Li B, Ma TF, Leung WK. High-dose proton pump inhibitors are associated with hospitalisation in bronchiectasis exacerbation. Int J Tuberc Lung Dis. 2022;26(10):917-21.  
16. Kwok WC, Ma TF, Chan JWM, Pang HH, Ho JCM. A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity. BMC Pulm Med. 2022;22(1):128.  
17. Kwok WC, Chiang KY, Ho JCM, Lam DCL, Ip MSM, Tam TCC. Risk factors of nephrotoxicity of maintenance pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung. Lung Cancer. 2021;162:169-74.  
18. Kwok WC, Ho JCM, Tam TCC, Ip MSM, Lam DCL. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respir Res. 2021;22(1):132.   
19. Kwok WC, Cheong TF, Chiang KY, Ho JCM, Lam DCL, Ip MSM, Tam TCC. Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. Lung Cancer. 2020;152:15-20. 
20. Kwok WC, Liang BM, Lui MMS, Tam TCC, Sim JPY, Tse EWC, Leung AYH, Kwong YL, Lie AKW, Ip MSM, Lam DCL. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome. Respirology. 2019;24(5):459-66.